Ecopetrol
EC
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Meritage Homes
MTH
KB Home
KBH
US Stock MarketDetailed Quotes
ABBV AbbVie
- 176.740
- -1.270-0.71%
Trading Dec 30 11:38 ET
312.32BMarket Cap61.58P/E (TTM)
177.340High175.510Low694.30KVolume177.375Open178.010Pre Close122.25MTurnover0.04%Turnover Ratio64.98P/E (Static)1.77BShares207.32052wk High51.78P/B311.41BFloat Cap150.97452wk Low6.13Dividend TTM1.76BShs Float207.320Historical High3.47%Div YieldTTM1.03%Amplitude20.016Historical Low176.081Avg Price1Lot Size
About AbbVie Company
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Company Profile
SymbolABBV
Company NameAbbVie
Listing DateDec 10, 2012
Founded2011
CEOMr. Robert A. Michael
MarketNYSE
Employees50000
Fiscal Year Ends12-31
Address1 North Waukegan Road
CityNorth Chicago
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-847-932-7900
Websitehttp://www.abbvie.com
Company Executives
- Name
- Position
- Salary
- Robert A. Michael
- Director and Chief Executive Officer
- 14.44M
- Scott Reents
- Executive Vice President and Chief Financial Officer
- 10.19M
- Jeffrey Ryan Stewart
- Executive Vice President and Chief Commercial Officer
- 15.35M
- Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD
- Executive Vice President and Chief Operations Officer
- 9.30M
- Dr. Roopal Thakkar, M.D.
- Senior Vice President and Chief Medical Officer, Global Therapeutics
- --
- Dr. Nicholas Donoghoe
- Executive Vice President, Chief Business and Strategy Officer
- --
- Dr. Thomas J. Hudson, M.D.
- Senior Vice President and Chief Scientific Officer, Global Research
- --
- Timothy J. Richmond
- Executive Vice President and Chief Human Resources Officer
- --
- Kevin K. Buckbee
- Senior Vice President, Controller and Principal Accounting Officer
- --
- David R. Purdue
- Vice President, Commercial Operations and Controller
- --
- Perry C. Siatis
- Executive Vice President, General Counsel and Secretary
- --
- Richard A. Gonzalez
- Chairman of the Board
- 25.66M
- Brett J. Hart
- Independent Director
- 384.98K
- Melody B. Meyer
- Independent Director
- 369.98K
- Frederick H. Waddell
- Independent Director
- 369.98K
- William H.L. Burnside
- Independent Director
- 377.48K
- Glenn F. Tilton
- Lead Independent Director
- 421.58K
- Dr. Susan E. Quaggin, M.D.
- Independent Director
- 24.00K
- Dr. Robert J. Alpern,M.D.
- Independent Director
- 461.18K
- Jennifer L. Davis
- Independent Director
- 45.00K
- Rebecca B. Roberts
- Independent Director
- 359.98K
- Roxanne S. Austin
- Independent Director
- 388.39K
- Thomas C. Freyman
- Independent Director
- 389.98K
- Edward J. Rapp
- Independent Director
- 394.98K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.